NCT04728802 - Proxalutamide Treatment for Hospitalized COVID-19 Patients | Biotech Hunter

Enrollment

645

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

April 15, 2021

Study Completion Date

April 15, 2021

Conditions

Covid19SARS (Severe Acute Respiratory Syndrome)

Interventions

DRUG

Proxalutamide

Proxalutamide 300mg q.d

DRUG

Placebo

Placebo pill

Trial Locations (8)

Hospital Regional José Mendes, Itacoatiara

Hospital de Campanha de Manacapuru, Manacapuru

Hospital Oscar Nicolau, Manaus

Hospital Prontocord, Manaus

Hospital Samel, Manaus

Hospital Regional Dr. Hamilton Maia Cidae, Manicoré

Hospital Raimunda Francisca Dinelli da Silva, Maués

Hospital Regional Jofre Cohen, Parintins